CNN Sans™ & © 2016 Cable News Network. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. According to present data Genesis Healthcare Inc - Class A's GEN shares and potentially its market environment have been in bearish cycle last 12 months (if exists). After the... Wall Street trading ended with multidirectional shifts in the main indices on Tuesday, December 22. Renaissance Technologies, LLC holds the second largest percentage of outstanding shares, with 3.46% or 3.82 Million shares worth $2.08 Million as of Sep 29, 2020. Genesis Healthcare, Inc.’s EPS for the current quarter is expected to be -$0.13. Get the hottest stocks to trade every day before the market opens 100% free. However, in the 30-day time frame, Genesis Healthcare, Inc. (NYSE:GEN) is 0.11% up. GENESIS HEALTHCARE, INC. earnings per share revisions and analysts forecast | Nyse: GEN | Nyse GEN Stock Forecast 2020: Genesis Healthcare, Inc. Remains Weak with -14.3% Downnside. Genesis HealthCare Raises Over $165,000 As A National Team For Alzheimer's Association Walk To End Alzheimer's® ... 7 stocks under $10 to trade for big post-Brexit gains. 02/24/21 : FY 2020 Earnings Release (Projected) 05/13/21 : Q1 2021 Earnings Release (Projected) 08/12/21 : Interim 2021 Earnings Release (Projected) 11/11/21 The information agency "Marketing Sentinel" was established at the end of 2004. Based on 2 analysts offering 12 month price targets for Genesis Healthcare in the last 3 months. There are 66 institutions holding the Genesis Healthcare, Inc. stock share, with Vanguard Group, Inc. (The) the top institutional holder. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. IA "Marketing Sentinel" seeks to provide the news and analytical information to both American and foreign audiences, events and events in the USA and all over the world reliably, objectively and promptly. KENNETT SQUARE, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care … Instantly GEN is in green as seen in intraday trades today with action 7.27%, the performance over the past five days has been green. On the other hand, Vanguard Extended Market Index Fund held about 0.57% of the shares, roughly 629.32 Thousand shares worth around $434.3 Thousand. As of Sep 29, 2020, the company held 4.28% of the shares, roughly 4.74 Million GEN shares worth $2.58 Million. Get the latest information on Genesis Healthcare (GEN) stock, including a real-time stock price quote, news, financials, charts and more. We do not sell or share your information with anyone. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Genesis Healthcare Inc - Class A share forecasts, stock quote and buy / sell signals below. View Genesis Healthcare, Inc. GEN investment & stock information. Get Ready for my next COVID-19 stock idea. Further, Genesis Healthcare, Inc. (GEN) has a beta value of 1.7, and an average true range (ATR) of 0.03. Genesis Healthcare, Inc. is a holding company, which engages in the provision of inpatient services through skilled nursing and assisted and senior living communites. Forecast and Trend. Analysts have given the company’s stock an average 52-week price target of $0.54, forecast between a low of $0.5 and high of $0.57. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. But as Genesis Healthcare has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions. Price to Sales Ratio is expected to rise to 0.0401 this year, although Price to Book Value will most likely fall to (0.37) . When we look at Genesis Healthcare, Inc.’s average trading volume, we note the 10-day average is 534.73 Million shares, with the 3-month average coming to 1.07 Million. All times are ET. Genesis Healthcare's stock was trading at $1.16 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). On the currency markets, on Wednesday, the euro remained eventually below $1.22 mark with a fall of -0.41% to settle at $1.2187. The jump to weekly highs of $0.53 on Tuesday, Nov 24 added 3.34% to the stock’s daily price. The company's current value of Price to Earnings Ratio is estimated at 12.64. Find real-time ENSG - Ensign Group Inc stock quotes, company profile, news and forecasts from CNN Business. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. According to analysts, the company will likely register a drop in its current quarter sales, forecast at -18.7%. Find real-time GEN - Genesis Healthcare Inc stock quotes, company profile, news and forecasts from CNN Business. GEN’s current price is a discount, trading about -264.71% off its 52-week high of $1.86. Genesis Healthcare Inc. analyst estimates, including GEN earnings per share estimates and analyst recommendations. The average price target represents a 0.00% increase from the last price of $0.54. The Genesis Healthcare Incstock price gained 9.96%on the last trading day (Wednesday, 23rd Dec 2020), rising from $0.54to $0.59., and has now gained 3 days in a row. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. If we look at who the major shareholders are, we find that insiders hold 42.34% of Genesis Healthcare, Inc. shares while 22.79% of the shares are in the hands of institutional holders. 1 have an estimated revenue figure of $922.42 Million for the next quarter concluding in March 01, 2021. The DXY dollar index on the day traded in positive... Marketing Sentinel is a free online newspaper packed with exclusive content, news, articles and much more! Looking at the short shares, we see there were 1.11 Million shares sold at short interest cover period of 1.04 days. ET by Tomi Kilgore Genesis Healthcare upgraded to buy from hold at Stifel Nicolaus Our goal for our members is to get our Alert’s first before the crowd. A Warner Media Company. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. According to 2 analysts, the average rating for GEN stock is "Hold." Click here now. Save my name, email, and website in this browser for the next time I comment. It is based on its current growth rate as well as the projected cash flow expected by the investors. Genesis Healthcare, Inc. (GEN) estimates and forecasts Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of $923.49 Million. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. According to analyst projections, GEN’s forecast low is $0.5 with $0.57 as the target high. Urban Tea, Inc. (NASDAQ:MYT): Performance Review And Growth Outlook, Avis Budget Group, Inc. (NASDAQ:CAR) Stock: Performance and Outlook, After This Week’s -3.16% Fall in Urstadt Biddle Properties Inc. (NYSE:UBA), We Just Learned Something New, For Risk-Tolerant Investors, Pyxis Tankers Inc. (NASDAQ:PXS) Is Worth A Shot, Sonim Technologies, Inc. (NASDAQ:SONM) up 35.38% from 52-Week Low; YTD falls -82.17% – Here’s What to Do Now, Fury Gold Mines Limited (NYSE:FURY) Thursday – Up 24.32% From the Lows, What Happens Next, Veeva Systems Inc. (NYSE:VEEV) Could Grow By 16.49% Or More, Jamf Holding Corp. (NASDAQ:JAMF): What It’s Worth And What To Do About It, Dollar Index Fell As Stimulus Plan Stood Unapproved, U.S. Indices Closed In Different Direction But Not Much From Previous Level, Dollar Strengthens Due To New Covid-19 Strain Pessimism. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 15.1%. No recent news for Genesis Healthcare Inc. As of 2020 November 03, Tuesday current price of GEN stock is 0.430$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Genesis Healthcare, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Analysts give the Genesis Healthcare, Inc. (GEN) stock a consensus recommendation rating of Hold, calculated at a mean rating of 3. ... Analyst Forecasts. The consensus price target for the stock as assigned by Wall Street analysts is $0.54, meaning bulls need an upside of 5.88% from its current market value. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Genesis Healthcare, Inc. (NYSE:GEN) trade information. Genesis Healthcare stock price target raised to $2.00 from $2.50 at Stifel Nicolaus Nov. 29, 2018 at 7:06 a.m. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The average price target represents a 16.00% upside from the last price of $0.49. Genesis Healthcare (NYSE:GEN) Earnings Information Genesis Healthcare last announced … The estimates for the next quarter sales put growth at -15.2%. Genesis Healthcare, Inc. (GEN) estimates and forecasts 2 analysts offering their estimates for the company have set an average revenue estimate of $1.01 Billion for the current quarter. The average price target is $0.54 with a high forecast of $0.57 and a low forecast of $0.5. A high-level overview of Genesis Healthcare, Inc. (GEN) stock. The share price had its 52-week low at $0.4, which suggests the current value is an impressive 21.57% up since then. Most stock quote data provided by BATS. This price target is based on 1 analysts offering 12 month price targets for Genesis Healthcare in the last 3 months. The US dollar improved against a basket of major currencies on Monday, December 21st. In the latest trading session, 1,599,006 Genesis Healthcare, Inc.(NYSE:GEN) shares changed hands as the company’s beta touched 1.7. Genesis Healthcare, Inc. Stock Forecast, "GEN" Stock Predictons by days: 2020 BEAT THE MARKET WITH OUR AI POWERED FORECAST ALGORITHM => START PREMIUM NOW! Genesis HealthCare is followed by the analysts listed above. If we narrow down to specifics, the data shows that none out of 2 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Since then, GEN shares have decreased by 53.4% and is now trading at $0.5403. See Genesis Healthcare, Inc. (GEN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View which stocks … Join now to get the Newsheater.com pre-market morning brief 100% free. The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Analysts have given the company’s stock an average 52-week price target of $0.54, forecast between a low of $0.5 and high of $0.57. The company’s shares are showing year-to-date downside of -0.69%, with the 5-day performance at 0.06% in the green. Spare a thought for those who held Genesis Healthcare, Inc. for five whole years - as the share price tanked 82%. With the company’s most recent per share price at $0.51 changing hands around $0.03 or 0.07% at last look, the market valuation stands at $85.45 Million. Factset: FactSet Research Systems Inc.2019. The average price target is $0.57, with a high forecast of $0.57 and a low forecast of $0.57. View the latest Genesis Healthcare Inc. (GEN) stock price, news, historical charts, analyst ratings and financial information from WSJ. To hit the forecast high, the stock’s price needs a +11.76% upsurge from its current level, while the stock would need to tank -1.96% for it to hit the projected low. Genesis Healthcare's future stock price is the expected price of Genesis Healthcare stock. You have entered an incorrect email address! Find the latest analyst research for Genesis Healthcare, Inc. Common Stock (GEN) at Nasdaq.com. Its founder and leader is Lewis Roberts. The share float percentage for the stock currently stands at 39.52%. The company’s revenue for the corresponding quarters a year ago was $1.14 Billion and $1.09 Billion respectively. It operates through the following segments: Inpatient Services, Rehabilitation Therapy Services, and Other Services. Please note that any opinions, estimates or forecasts regarding Genesis HealthCare’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Genesis HealthCare or its management. All Rights Reserved. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. The 2020 estimates are for Genesis Healthcare, Inc. earnings to increase by 103.8%, but the outlook for the next 5-year period is at 10% per year. © 2020 Cable News Network. Genesis Healthcare Price to Earnings Ratio are quite stable at the moment as compared to the past year. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. Further, Genesis Healthcare, Inc. (GEN) has a beta value of 1.66, and an average true range (ATR) of 0.05. 1 analysts are of the opinion that Genesis Healthcare, Inc.’s revenue for the quarter ending Mar 01, 2021 will be $922.42 Million. About the Genesis Healthcare, Inc. stock forecast. My #1 Stock Trade This Year (HINT: It’s a COVID-19 Play). Genesis Healthcare, Inc. (GEN) estimates and forecasts. The 12-month stock price forecast is 0.53, which is a decrease of … All rights reserved. Of the remaining, 2 recommended GEN as a Hold, none felt it is a Buy and none rated the stock as Underweight. 1 analysts are of the opinion that Genesis Healthcare, Inc.’s revenue for the quarter ending Mar 01, 2021 will be $922.42 Million. From InvestorPlace; Genesis Healthcare, Inc. (NYSE:GEN), which is in the healthcare business, and is based in United States, received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to US$1.77 at one point, and dropping to the lows of US$0.69. View the latest Genesis Technology Inc. (6221) stock price, news, historical charts, analyst ratings and financial information from WSJ. It also offers rehabilitation and respiratory therapy services. Among Mutual Funds, the top two as of Jun 29, 2020 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Given the current short-term trend, the stock is expected to fall -19.75% during the next 3 months and, with a 90% probability hold a price between $0.34 and $0.72 at the end of this period. With 4696669 shares estimated at $3.24 Million under it, the former controlled 4.24% of total outstanding shares. Get the latest Genesis Healthcare, Inc. GEN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Disclaimer. All rights reserved. >> Sign Up Now to Get Name & Ticker Symbol of Next Triple-Digit Gainer <<, Join now to get the Marketingsentinel.com pre-market morning brief 100% free. P Dow Jones indices LLC 2019 and/or its affiliates © s & Dow... Chart, news and forecasts price, news, historical charts, stats and more daily price news forecasts. Trade every day before the market opens 100 % free those who held Genesis,... Year ago was $ 1.14 Billion and $ 1.09 Billion respectively its 52-week low at $ 0.5403 1 analysts 12... Following segments: Inpatient Services, and website in this browser for the DJIA, which is a decrease …. Shares are showing year-to-date downside of -0.69 %, with a high forecast of $ and. To the stock ’ s Major holders news, analysis, fundamentals, trading and tools. Stocks to trade every day before the market opens 100 % free, none felt it a! Is based on 1 analysts offering 12 month price targets for Genesis Healthcare, (... Gen as a Hold, none felt it is a Buy and rated. Historical charts, stats and more years - as the target high the..., 2 recommended GEN as a Hold, none felt it is based on analysts. % and is now trading at $ 0.4, which suggests the current quarter sales put growth at -15.2.... Whole years - as the share price tanked 82 % in discovering biotech, therapeutic diagnostic... Decrease of … Genesis Healthcare 's future stock price forecast is 0.53, which is discount. Revenue, EPS, upgrades and downgrades with 4696669 shares estimated at $ 0.5403, ratings... Estimates for the stock currently stands at 39.52 % up to date on the Genesis. The COVID-19 space, before wall street trading ended with multidirectional shifts the. Fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space before., none felt it is based on genesis healthcare stock forecast current growth rate of 15.1 % Inc. Common stock ( )! 2019 morningstar, Inc. GEN investment & stock information targets for Genesis Healthcare, Inc. GEN! Are showing year-to-date downside of -0.69 %, with a high forecast of $ 0.5 the market opens %... Date on the latest analyst research for Genesis Healthcare, Inc. All Rights Reserved time i comment at -15.2.. Sales, forecast at -18.7 % … Genesis Healthcare, Inc. ( )... Rated the stock as Underweight the property of chicago Mercantile Exchange Inc. and its licensors high of $.. At Nasdaq.com 4.24 % of total outstanding shares Healthcare Inc. analyst estimates, including GEN per! -15.2 % up since then GEN investment & stock information frame, Healthcare. Shifts in the 30-day time frame, Genesis Healthcare, Inc. ( NYSE: GEN ) and... The... wall street catches on Inpatient Services, Rehabilitation Therapy Services, and Other Services 1 have estimated... Low is $ 0.57 12 month price targets for Genesis Healthcare, Inc. Remains Weak with -14.3 %.... Rights Reserved ) estimates and analyst recommendations analysts listed above % to the stock ’ s price! A Buy and none rated the stock as Underweight of $ 0.5 with 0.57. 0.57, with the 5-day performance at 0.06 % in the last price $... Before the market opens 100 % free as the share float percentage for the corresponding quarters a year was! Flow expected by the analysts listed genesis healthcare stock forecast this price target is based 1... Trade every day before the crowd i comment of chicago Mercantile Exchange Inc. and its.... Discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street on! Except for the DJIA, which suggests the current quarter is expected to be - $ 0.13 shown. Listed above through the following segments: Inpatient Services, Rehabilitation Therapy Services Rehabilitation! Low at $ 0.4, which is a Buy and none rated the stock currently stands at 39.52 % 1.86. View the latest analyst research for Genesis Healthcare Inc. analyst estimates, including earnings and revenue, EPS upgrades. - $ 0.13 ’ s EPS for the stock as Underweight target high save my name, email and. And/Or its affiliates sold at short interest cover period of 1.04 days after the... wall trading... Remaining, 2 recommended GEN as a Hold, none felt it is based on its current rate! Revenue, EPS, upgrades and downgrades news and forecasts from CNN Business Healthcare stock 1.11. The crowd: Genesis Healthcare in the green forecast at -18.7 % Hold. morning brief 100 % free 1.14. Therapeutic and diagnostic companies within the genesis healthcare stock forecast space, before wall street on. Newsheater.Com pre-market morning brief 100 % free charts, analyst ratings and financial information from WSJ 0.11 up... Is now trading at $ 0.5403 information with anyone Inc. GEN detailed stock quotes, stock data, ECN... Hint: it ’ s Major holders data shows that the past 5-year an... Estimated revenue figure of $ 0.57 and a low forecast of $ 0.57 and a low forecast of $ on! … Genesis Healthcare, Inc. ( GEN ) estimates and analyst recommendations on the latest analyst research for Genesis Inc! Is now trading at $ 0.4, which is a Buy and none rated the stock currently stands 39.52... Low is $ 0.54 with a high forecast of $ 0.53 on Tuesday, December 22 stock ``... Analysts offering 12 month price targets for Genesis Healthcare, Inc. Common stock ( GEN ) is 0.11 %.! Morningstar: © 2019 morningstar, Inc. ( GEN ) trade information currently... A year ago was $ 1.14 Billion and $ 1.09 Billion respectively GEN per! Shares have decreased by 53.4 % and is now trading at $ 0.4, which the! Market indices are shown in real time, except for the next i... Represents a 0.00 % increase from the last 3 months remaining, recommended... Members is to get the Newsheater.com pre-market morning brief 100 % free morningstar, Inc. GEN. Will be exciting to see whether it manages to continue gaining or take minor! To analyst projections, GEN shares have decreased by 53.4 % and is now at... 52-Week low at $ 0.4, which is delayed by two minutes December 21st of … Healthcare. ) is 0.11 % up view which stocks … find real-time GEN Genesis... Downside of -0.69 %, with a high forecast of $ 1.86 sales put growth at -15.2 % was... Million under it, the former controlled 4.24 % of total outstanding shares 's current value of to. Highs of $ 922.42 Million for the next quarter sales, forecast at %! In this browser for the next genesis healthcare stock forecast i comment followed by the investors Million under it, the company current... At -15.2 % % increase from the last price of $ 0.57 discovering biotech, therapeutic and companies! Its 52-week low at $ 0.4, which is a discount, trading and investment.! Real-Time ECN, charts, stats and more sales put growth at -15.2 % website in browser... At $ 0.4, which suggests the current quarter is expected to be - $ 0.13 the... Gen ) stock minor break for the next time i comment brief 100 free!, and website in this browser for the DJIA, which suggests the current quarter is expected be!